News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance



1/7/2013 8:24:01 AM

Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reiterated today that it expects revenue for the fourth quarter and full year of 2012 to be in the range $75.8 to $78.8 million and $274.0 to $277.0 million, respectively, consistent with the Company’s revenue guidance issued on November 5, 2012.

Read at BioSpace.com


comments powered by Disqus
Tornier
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES